Marianne Davies on Evidence- Based Practice at YNHH

Article

Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the benefits of the nursing research and evidence-based practice council at Yale-New Haven Hospital.

Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the benefits of the nursing research and evidence-based practice council at Yale-New Haven Hospital.

Davies says that the structure of the council, as it provides protected time to meet, helps to support research at Yale-New Haven Hospital. The institution also provides opportunity for professional and career development as well as patient-centered research initiatives.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Image of a woman with light brown hair wearing glasses with a blue background
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Related Content
Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC
June 30th 2025
Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

Equity, Diversity, and Inclusion in Oncology Nursing Leadership

Equity, Diversity, and Inclusion in Oncology Nursing Leadership

Lindsay Fischer
December 1st 2022
Podcast

For this episode of “The Vitals,” Aliènne Salleroli, MS, BSN, RN, OCN, discusses her research on equity, diversity, and inclusion in oncology nurse leadership.

breast cancer

DESTINY-Breast02 Confirms Benefit of Trastuzumab Deruxtecan in Previously Treated Patients With HER2+ Metastatic Breast Cancer

Sailaja Darisipudi
December 10th 2022
Article

In the second-line setting, patients with advanced HER2-positive breast cancer derived a superior clinical benefit with trastuzumab deruxtecan compared with treatment with physician’s choice of treatment.

The Value of Nurse Mentorship in Oncology

The Value of Nurse Mentorship in Oncology

Lindsay Fischer
January 15th 2022
Podcast

In this episode of “The Vitals,” 2 veteran oncology nurses discuss the value of mentorship—particularly for novice nurses.

Adding Cediranib to Olaparib Increases Treatment Efficacy, But Raises Toxicity Concerns, in mCRPC

Adding Cediranib to Olaparib Increases Treatment Efficacy, But Raises Toxicity Concerns, in mCRPC

Ashling Wahner
October 29th 2022
Article

A regimen of cediranib and olaparib improved radiographic progression-free survival in patients with metastatic castration-resistant prostate cancer compared with olaparib monotherapy. However, the rate of dose reductions was doubled with the combination.

Oncology Therapy at the End of Life: Have We Missed the Mark?

Oncology Therapy at the End of Life: Have We Missed the Mark?

Yale Cancer Center
October 28th 2022
Article

"Over the last decade, the landscape of systemic anti-cancer therapy has changed dramatically following the approvals of multiple new targeted therapies," - Kerin Adelson, MD.